RichardJRosenbluthMD

PubMed

• It is time to revisit the subject of cancer in the elderly patient, the editors of Clinics in Geriatric Medicine have correctly decided. Introduction.
  Richard Rosenbluth> ;Clinics in Geriatric Medicine. 2012 Feb 1
• 50 citations
  Association of coping style, pain, age and depression with fatigue in women with primary breast cancer.
  Katrin Reuter, Catherine C. Classen, Joseph A. Roscoe, Gary R. Morrow, Jeffrey J. Kirshner, Richard J. Rosenbluth, Patrick J. Flynn, Kathleen Shedlock, David Spiegel> ;Psycho-Oncology. 2006 Sep 1
• 26 citations
  Stability of decisional role preference over the course of cancer therapy.
  Julie B. Mallinger, Cleveland G. Shields, Jennifer J. Griggs, Joseph A. Roscoe, Gary R. Morrow, Richard J. Rosenbluth, Raymond S. Lord, Howard M. Gross> ;Psycho-Oncology. 2006 Apr 1
• Are cancer patients utilizing complementary therapies? A URCC CCOP study.
  Yates J, Morrow G, Mustian K, Hofman M, Bushunow P, Flynn PJ, Rosenbluth R, Atkins J> ;J. Clin. Oncol.. 2004-07-15
• 10 citations
  Treatment of leukemic relapse following unrelated umbilical cord blood transplantation with interleukin-2: potential for augmenting graft-versus-leukemia and graft-ver...
  Stuart L. Goldberg, Andrew L. Pecora, Richard J. Rosenbluth, Andrew Jennis, Robert A. Preti> ;Bone Marrow Transplantation. 2000 Aug 1
• 210 citations
  Oral Clonidine in Postmenopausal Patients with Breast Cancer Experiencing Tamoxifen-Induced Hot Flashes: A University of Rochester Cancer Center Community Clinical Onc...
  Kishan J. Pandya, Richard F. Raubertas, Patrick J. Flynn, Harry E. Hynes, Richard J. Rosenbluth, Jeffrey J. Kirshner, H. Irving Pierce, Vladimir Dragalin, Gary R. Morrow> ;Annals of Internal Medicine. 2000 May 16
• 89 citations
  Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilic...
  Andrew L. Pecora, Patrick J. Stiff, Andrew Jennis, Stuart L. Goldberg, Richard J. Rosenbluth, Paul C. Price, K L Goltry, J Douville, R D Armstrong, AK Smith, Robert A....> ;Bone Marrow Transplantation. 2000 Apr 1
• 17 citations
  Use of 5‐HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings
  M.P.H. Jane T. Hickok M.D., Joseph A. Roscoe, Gary R. Morrow, Robert M. Stern, Bo Yang, Patrick J. Flynn, Harry E. Hynes, Jeffrey J. Kirshner, Richard J. Rosenbluth> ;Cancer. 1999 Jul 1
• 65 citations
  Anticipatory Nausea and Vomiting in the Era of 5-HT3 Antiemetics
  Gary R. Morrow, Joseph A. Roscoe, Jeffrey J. Kirshner, Harry E. Hynes, Richard J. Rosenbluth> ;Supportive Care in Cancer. 1998 May 1
• 31 citations
  A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix
  William P. Irvin, Fredric V. Price, Howard H. Bailey, Mark S. Gelder, Richard J. Rosenbluth, Henry J. Durivage, Ronald K. Potkul> ;Cancer. 1998 Jan 15
• 9 citations
  Effectiveness of a training program for enhancing therapists' understanding of the supportive-expressive treatment model for breast cancer groups.
  Catherine C. Classen, S Abramson, Karyn Angell, Ami Atkinson, C Desch, Vincent Vinciguerra, Richard J. Rosenbluth, Jeffrey J. Kirshner, R Hart, Gary R. Morrow, David S...> ;The Journal of Psychotherapy Practice and Research. 1997 Jan 1
• 14 citations
  Phase II study of goserelin for patients with postmenopausal metastatic breast cancer.
  Thomas James Saphner, A B Troxel, Douglass C. Tormey, Donna Neuberg, Nicholas J. Robert, Kishan J. Pandya, John H. Edmonson, Richard J. Rosenbluth, Martin D. Abeloff> ;Journal of Clinical Oncology. 1993 Aug 1
• 63 citations
  A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic c...
  David P. Kelsen, Clifford A. Hudis, Donna Niedzwiecki, James Dougherty, Ephraim S. Casper, Jose Botet, Vincent Vinciguerra, Richard Rosenbluth> ;Cancer. 1991 Sep 1
• 35 citations
  Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results.
  Susan A. Kambhu, David P. Kelsen, John J. Fiore, Donna Niedzwiecki, Douglas Chapman, Vincent Vinciguerra, Richard Rosenbluth> ;American Journal of Clinical Oncology. 1990 Feb 1
• 82 citations
  Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer
  Nancy E. Kemeny, K Israel, Donna Niedzwiecki, Douglass Chapman, Jose Botet, Bruce D. Minsky, Vincent Vinciguerra, Richard Rosenbluth, B Bosselli, C Cochran> ;Journal of Clinical Oncology. 1990 Feb 1
• 10 citations
  Phase II Trial of Trimetrexate in Patients with Advanced Renal Cell Carcinoma
  Cora N. Sternberg, Alan Yagoda, Howard I. Scher, George J. Bosl, D. David Dershaw, Kim Rosado, Collette Houston, Richard Rosenbluth, Vincent Vinciguerra, Bruce Boselli> ;European Journal of Cancer & Clinical Oncology. 1989 Apr 1
• 10 citations
  Cisplatin and 5-fluorouracil infusion for metastatic colorectal carcinoma. Differences in survival in two patient groups with similar response rates.
  Nancy E. Kemeny, Donna Niedzwiecki, Bonnie Reichman, Jose Botet, Vincent Vinciguerra, R A Michaelson, Richard Rosenbluth, S. Deonarine> ;Cancer. 1989 Mar 15
• 7 citations
  Combination hormone therapy for metastatic breast cancer. An ECOG study of megestrol and aminoglutethimide.
  John Horton, Matthew Knuiman, Alan M. Keller, Harriett Vogel, Kenneth E. Gale, Richard G. Hahn, Richard J. Rosenbluth, Douglass C. Tormey> ;Cancer. 1987 Nov 1
• 13 citations
  DON, CONV and DONV—III. Pharmacologic and toxicologic studies
  David A. Cooney, Hiremagalur N. Jayaram, Harry A. Milman, Elton R. Homan, Robert F. Pittillo, Ruth I. Geran, Joan Ryan, Richard J. Rosenbluth> ;Biochemical Pharmacology. 1976 Aug 15
• 3 citations
  DON, CONV and DONV-II. Inhibition of L-'asparagine synthetase in vivo.
  R J Rosenbluth, D A Cooney, H N Jayaram, H A Milman, E R Homan> ;Biochemical Pharmacology. 1976 Aug 15
• 21 citations
  Enzymes as therapeutic agents.
  David A. Cooney, Richard J. Rosenbluth> ;Advances in Pharmacology and Chemotherapy. 1975 Jan 1
• Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain.
  Citron, M. L., Kaplan, R., Parris, W. C., Croghan, M. K., Herbst, L. H., Rosenbluth, R. J., Reder, R. F., Slagle, N. S., Buckley, B. J., Kaiko, R. F.> ;Cancer Invest. 1998
• Don, conv and donv--I. Inhibition of L-asparagine synthetase in vitro.
  Jayaram, H. N., Cooney, D. A., Milman, H. A., Homan, E. R., Rosenbluth, R. J.> ;Biochem Pharmacol. 1976 Jul 15
• Join now to see all